Skip navigation

Chemical Cytokines

1–50 of 60 results.
  Chemical Phenotype Co-Mentioned Terms Interaction Organisms Anatomy Inference Network References
1. Cytokines cell proliferation Cyclosporine Cyclosporine inhibits the reaction [Cytokines results in increased cell proliferation] 1: Mus musculus Mast Cells   1
2. Cytokines cell proliferation Tacrolimus Tacrolimus inhibits the reaction [Cytokines results in increased cell proliferation] 1: Mus musculus Mast Cells   1
3. Cytokines cell proliferation Cytokines results in increased cell proliferation 1: Mus musculus Mast Cells   1
4. Erythropoietin apoptotic process 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | Doxorubicin 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Erythropoietin inhibits the reaction [Doxorubicin results in increased apoptotic process]] 1: Rattus norvegicus Heart Ventricles | Muscle Cells
2 genes: SIRT1 | VDAC1
1
5. Erythropoietin cell death Doxorubicin Erythropoietin inhibits the reaction [Doxorubicin results in increased cell death] 1: Homo sapiens Myocytes, Cardiac | Cell Line   1
6. Erythropoietin ATP biosynthetic process Doxorubicin | SIRT1 SIRT1 protein affects the reaction [Erythropoietin inhibits the reaction [Doxorubicin results in decreased ATP biosynthetic process]] 1: Homo sapiens Myocytes, Cardiac | Cell Line | Mitochondria   1
7. Erythropoietin reactive oxygen species biosynthetic process Doxorubicin Erythropoietin inhibits the reaction [Doxorubicin results in increased reactive oxygen species biosynthetic process] 1: Homo sapiens Myocytes, Cardiac | Cell Line | Mitochondria   1
8. Erythropoietin regulation of mitochondrial membrane potential Doxorubicin | SIRT1 SIRT1 protein affects the reaction [Erythropoietin inhibits the reaction [Doxorubicin affects regulation of mitochondrial membrane potential]] 1: Homo sapiens Myocytes, Cardiac | Cell Line 1 gene: SOD2 1
9. Erythropoietin regulation of mitochondrial membrane potential Doxorubicin Erythropoietin inhibits the reaction [Doxorubicin affects regulation of mitochondrial membrane potential] 1: Homo sapiens Myocytes, Cardiac | Cell Line 1 gene: SOD2 1
10. Erythropoietin superoxide anion generation Doxorubicin | SIRT1 SIRT1 protein affects the reaction [Erythropoietin inhibits the reaction [Doxorubicin results in increased superoxide anion generation]] 1: Homo sapiens Myocytes, Cardiac | Cell Line | Mitochondria 1 gene: SOD2 1
11. Erythropoietin mitochondrial DNA replication Erythropoietin results in increased mitochondrial DNA replication 1: Homo sapiens Myocytes, Cardiac | Cell Line 1 gene: TFAM 1
12. Erythropoietin superoxide anion generation Doxorubicin Erythropoietin inhibits the reaction [Doxorubicin results in increased superoxide anion generation] 1: Homo sapiens Myocytes, Cardiac | Cell Line | Mitochondria 1 gene: SOD2 1
13. Erythropoietin ATP biosynthetic process Doxorubicin Erythropoietin inhibits the reaction [Doxorubicin results in decreased ATP biosynthetic process] 1: Homo sapiens Myocytes, Cardiac | Cell Line | Mitochondria   1
14. Erythropoietin apoptotic process Doxorubicin Erythropoietin inhibits the reaction [Doxorubicin results in increased apoptotic process] 1: Rattus norvegicus Heart Ventricles | Muscle Cells
2 genes: SIRT1 | VDAC1
1
15. Interleukin-5 cell chemotaxis Interleukin-5 results in increased cell chemotaxis 1: Homo sapiens Eosinophils   1
16. interferon alfa-2a positive regulation of JAK-STAT cascade 6-hydroxy-3-O-methylkaempferol 6-O-glucopyranoside | Janus Kinase Inhibitors Janus Kinase Inhibitors inhibits the reaction [6-hydroxy-3-O-methylkaempferol 6-O-glucopyranoside promotes the reaction [interferon alfa-2a results in increased positive regulation of JAK-STAT cascade]] 1: Homo sapiens Hep G2 Cells   1
17. interferon alfa-2a positive regulation of JAK-STAT cascade Janus Kinase Inhibitors Janus Kinase Inhibitors inhibits the reaction [interferon alfa-2a results in increased positive regulation of JAK-STAT cascade] 1: Homo sapiens Hep G2 Cells   1
18. interferon alfa-2a positive regulation of type I interferon-mediated signaling pathway Janus Kinase Inhibitors Janus Kinase Inhibitors inhibits the reaction [interferon alfa-2a results in increased positive regulation of type I interferon-mediated signaling pathway] 1: Homo sapiens Hep G2 Cells   1
19. interferon alfa-2a negative regulation of cell proliferation interferon alfa-2a results in increased negative regulation of cell proliferation 1: Homo sapiens Hepatocytes | Cell Line, Tumor
2 genes: EIF2AK2 | STAT3
1
20. interferon alfa-2a positive regulation of JAK-STAT cascade 6-hydroxy-3-O-methylkaempferol 6-O-glucopyranoside 6-hydroxy-3-O-methylkaempferol 6-O-glucopyranoside promotes the reaction [interferon alfa-2a results in increased positive regulation of JAK-STAT cascade] 1: Homo sapiens Hep G2 Cells   1
21. interferon alfa-2a positive regulation of JAK-STAT cascade interferon alfa-2a results in increased positive regulation of JAK-STAT cascade 1: Homo sapiens Hep G2 Cells   1
22. interferon alfa-2a negative regulation of cell proliferation 6-hydroxy-3-O-methylkaempferol 6-O-glucopyranoside 6-hydroxy-3-O-methylkaempferol 6-O-glucopyranoside promotes the reaction [interferon alfa-2a results in increased negative regulation of cell proliferation] 1: Homo sapiens Hepatocytes | Cell Line, Tumor
2 genes: EIF2AK2 | STAT3
1
23. interferon alfa-2a positive regulation of type I interferon-mediated signaling pathway 6-hydroxy-3-O-methylkaempferol 6-O-glucopyranoside 6-hydroxy-3-O-methylkaempferol 6-O-glucopyranoside promotes the reaction [interferon alfa-2a results in increased positive regulation of type I interferon-mediated signaling pathway] 1: Homo sapiens Hep G2 Cells   1
24. interferon alfa-2a positive regulation of type I interferon-mediated signaling pathway 6-hydroxy-3-O-methylkaempferol 6-O-glucopyranoside | Janus Kinase Inhibitors Janus Kinase Inhibitors inhibits the reaction [6-hydroxy-3-O-methylkaempferol 6-O-glucopyranoside promotes the reaction [interferon alfa-2a results in increased positive regulation of type I interferon-mediated signaling pathway]] 1: Homo sapiens Hep G2 Cells   1
25. interferon alfa-2a positive regulation of type I interferon-mediated signaling pathway interferon alfa-2a results in increased positive regulation of type I interferon-mediated signaling pathway 1: Homo sapiens Hep G2 Cells   1
26. Interferon beta-1b positive regulation of JAK-STAT cascade Interferon beta-1b results in increased positive regulation of JAK-STAT cascade 1: Homo sapiens Hep G2 Cells   1
27. Interferon beta-1b positive regulation of JAK-STAT cascade 6-hydroxy-3-O-methylkaempferol 6-O-glucopyranoside 6-hydroxy-3-O-methylkaempferol 6-O-glucopyranoside promotes the reaction [Interferon beta-1b results in increased positive regulation of JAK-STAT cascade] 1: Homo sapiens Hep G2 Cells   1
28. Interferon beta-1b positive regulation of type I interferon-mediated signaling pathway 6-hydroxy-3-O-methylkaempferol 6-O-glucopyranoside 6-hydroxy-3-O-methylkaempferol 6-O-glucopyranoside promotes the reaction [Interferon beta-1b results in increased positive regulation of type I interferon-mediated signaling pathway] 1: Homo sapiens Hep G2 Cells   1
29. Interferon beta-1b positive regulation of type I interferon-mediated signaling pathway Interferon beta-1b results in increased positive regulation of type I interferon-mediated signaling pathway 1: Homo sapiens Hep G2 Cells   1
30. Interleukin 1 Receptor Antagonist Protein positive regulation of neutrophil extravasation Interleukin 1 Receptor Antagonist Protein results in increased positive regulation of neutrophil extravasation 1: Mus musculus Peritoneal Cavity 1 gene: IL1A 1
31. Interleukin 1 Receptor Antagonist Protein positive regulation of cell proliferation Interleukin 1 Receptor Antagonist Protein results in increased positive regulation of cell proliferation 1: Homo sapiens Epithelial Cells | Cell Line, Tumor
5 genes: CSF3 | HMGB1 | IL1B | IL6 | TIMP1
1
32. Interleukin 1 Receptor Antagonist Protein leukocyte homeostasis Interleukin 1 Receptor Antagonist Protein affects leukocyte homeostasis 1: Homo sapiens Leukocytes   1
33. Lymphokines positive regulation of superoxide anion generation Nitroprusside [Lymphokines co-treated with Nitroprusside] results in increased positive regulation of superoxide anion generation 1: Cavia porcellus Macrophages, Peritoneal | Cells, Cultured   1
34. Lymphokines positive regulation of hydrogen peroxide biosynthetic process Lymphokines results in increased positive regulation of hydrogen peroxide biosynthetic process 1: Cavia porcellus Macrophages, Peritoneal | Cells, Cultured   1
35. Oncostatin M hepatocyte differentiation Ascorbic Acid | Butyric Acid | Carbon Tetrachloride | Dexamethasone | Dimethyl Sulfoxide | EGF | GATA4 | HGF | Niacinamide Carbon Tetrachloride inhibits the reaction [[[EGF protein co-treated with Oncostatin M co-treated with Dexamethasone co-treated with Niacinamide co-treated with Ascorbic Acid] affects the reaction [[HGF protein co-treated with Dimethyl Sulfoxide co-treated with Butyric Acid] results in increased hepatocyte differentiation]] which results in increased expression of GATA4 protein] 1: Mus musculus Embryonic Stem Cells   1
36. Oncostatin M hepatocyte differentiation Ascorbic Acid | Butyric Acid | Dexamethasone | Dimethyl Sulfoxide | EGF | HGF | KRT18 | Niacinamide [[EGF protein co-treated with Oncostatin M co-treated with Dexamethasone co-treated with Niacinamide co-treated with Ascorbic Acid] affects the reaction [[HGF protein co-treated with Dimethyl Sulfoxide co-treated with Butyric Acid] results in increased hepatocyte differentiation]] which results in increased expression of KRT18 protein 1: Mus musculus Embryonic Stem Cells   1
37. Oncostatin M hepatocyte differentiation Ascorbic Acid | Butyric Acid | Carbon Tetrachloride | Dexamethasone | Dimethyl Sulfoxide | EGF | HGF | L-aspartate:2-oxoglutarate aminotransferase activity | Niacinamide [[EGF protein co-treated with Oncostatin M co-treated with Dexamethasone co-treated with Niacinamide co-treated with Ascorbic Acid] affects the reaction [[HGF protein co-treated with Dimethyl Sulfoxide co-treated with Butyric Acid] results in increased hepatocyte differentiation]] affects the reaction [Carbon Tetrachloride affects L-aspartate:2-oxoglutarate aminotransferase activity] 1: Mus musculus Embryonic Stem Cells   1
38. Oncostatin M alkaline phosphatase activity Ascorbic Acid | Butyric Acid | Dexamethasone | Dimethyl Sulfoxide | EGF | Fluorouracil | hepatocyte differentiation | HGF | Niacinamide [[EGF protein co-treated with Oncostatin M co-treated with Dexamethasone co-treated with Niacinamide co-treated with Ascorbic Acid] affects the reaction [[HGF protein co-treated with Dimethyl Sulfoxide co-treated with Butyric Acid] results in increased hepatocyte differentiation]] affects the reaction [Fluorouracil affects alkaline phosphatase activity] 1: Mus musculus Embryonic Stem Cells   1
39. Oncostatin M hepatocyte differentiation Ascorbic Acid | Butyric Acid | Dexamethasone | Dimethyl Sulfoxide | EGF | HGF | Niacinamide [EGF protein co-treated with Oncostatin M co-treated with Dexamethasone co-treated with Niacinamide co-treated with Ascorbic Acid] affects the reaction [[HGF protein co-treated with Dimethyl Sulfoxide co-treated with Butyric Acid] results in increased hepatocyte differentiation] 1: Mus musculus Embryonic Stem Cells   1
40. Oncostatin M hepatocyte differentiation alkaline phosphatase activity | Ascorbic Acid | Butyric Acid | Dexamethasone | Dimethyl Sulfoxide | EGF | Fluorouracil | HGF | Niacinamide [[EGF protein co-treated with Oncostatin M co-treated with Dexamethasone co-treated with Niacinamide co-treated with Ascorbic Acid] affects the reaction [[HGF protein co-treated with Dimethyl Sulfoxide co-treated with Butyric Acid] results in increased hepatocyte differentiation]] affects the reaction [Fluorouracil affects alkaline phosphatase activity] 1: Mus musculus Embryonic Stem Cells   1
41. Oncostatin M L-aspartate:2-oxoglutarate aminotransferase activity Ascorbic Acid | Butyric Acid | Dexamethasone | Dimethyl Sulfoxide | EGF | Fluorouracil | hepatocyte differentiation | HGF | Niacinamide [[EGF protein co-treated with Oncostatin M co-treated with Dexamethasone co-treated with Niacinamide co-treated with Ascorbic Acid] affects the reaction [[HGF protein co-treated with Dimethyl Sulfoxide co-treated with Butyric Acid] results in increased hepatocyte differentiation]] affects the reaction [Fluorouracil affects L-aspartate:2-oxoglutarate aminotransferase activity] 1: Mus musculus Embryonic Stem Cells   1
42. Oncostatin M alkaline phosphatase activity Arsanilic Acid | Ascorbic Acid | Butyric Acid | Dexamethasone | Dimethyl Sulfoxide | EGF | hepatocyte differentiation | HGF | Niacinamide [[EGF protein co-treated with Oncostatin M co-treated with Dexamethasone co-treated with Niacinamide co-treated with Ascorbic Acid] affects the reaction [[HGF protein co-treated with Dimethyl Sulfoxide co-treated with Butyric Acid] results in increased hepatocyte differentiation]] affects the reaction [Arsanilic Acid affects alkaline phosphatase activity] 1: Mus musculus Embryonic Stem Cells   1
43. Oncostatin M lactate dehydrogenase activity Arsanilic Acid | Ascorbic Acid | Butyric Acid | Dexamethasone | Dimethyl Sulfoxide | EGF | hepatocyte differentiation | HGF | Niacinamide [[EGF protein co-treated with Oncostatin M co-treated with Dexamethasone co-treated with Niacinamide co-treated with Ascorbic Acid] affects the reaction [[HGF protein co-treated with Dimethyl Sulfoxide co-treated with Butyric Acid] results in increased hepatocyte differentiation]] affects the reaction [Arsanilic Acid affects lactate dehydrogenase activity] 1: Mus musculus Embryonic Stem Cells   1
44. Oncostatin M hepatocyte differentiation Arsanilic Acid | Ascorbic Acid | Butyric Acid | Dexamethasone | Dimethyl Sulfoxide | EGF | HGF | L-aspartate:2-oxoglutarate aminotransferase activity | Niacinamide [[EGF protein co-treated with Oncostatin M co-treated with Dexamethasone co-treated with Niacinamide co-treated with Ascorbic Acid] affects the reaction [[HGF protein co-treated with Dimethyl Sulfoxide co-treated with Butyric Acid] results in increased hepatocyte differentiation]] affects the reaction [Arsanilic Acid affects L-aspartate:2-oxoglutarate aminotransferase activity] 1: Mus musculus Embryonic Stem Cells   1
45. Oncostatin M hepatocyte differentiation Ascorbic Acid | Butyric Acid | Carbon Tetrachloride | Dexamethasone | Dimethyl Sulfoxide | EGF | HGF | KRT18 | Niacinamide Carbon Tetrachloride inhibits the reaction [[[EGF protein co-treated with Oncostatin M co-treated with Dexamethasone co-treated with Niacinamide co-treated with Ascorbic Acid] affects the reaction [[HGF protein co-treated with Dimethyl Sulfoxide co-treated with Butyric Acid] results in increased hepatocyte differentiation]] which results in increased expression of KRT18 protein] 1: Mus musculus Embryonic Stem Cells   1
46. Oncostatin M hepatocyte differentiation Arsanilic Acid | Ascorbic Acid | Butyric Acid | Dexamethasone | Dimethyl Sulfoxide | EGF | HGF | lactate dehydrogenase activity | Niacinamide [[EGF protein co-treated with Oncostatin M co-treated with Dexamethasone co-treated with Niacinamide co-treated with Ascorbic Acid] affects the reaction [[HGF protein co-treated with Dimethyl Sulfoxide co-treated with Butyric Acid] results in increased hepatocyte differentiation]] affects the reaction [Arsanilic Acid affects lactate dehydrogenase activity] 1: Mus musculus Embryonic Stem Cells   1
47. Oncostatin M L-aspartate:2-oxoglutarate aminotransferase activity Ascorbic Acid | Butyric Acid | Carbon Tetrachloride | Dexamethasone | Dimethyl Sulfoxide | EGF | hepatocyte differentiation | HGF | Niacinamide [[EGF protein co-treated with Oncostatin M co-treated with Dexamethasone co-treated with Niacinamide co-treated with Ascorbic Acid] affects the reaction [[HGF protein co-treated with Dimethyl Sulfoxide co-treated with Butyric Acid] results in increased hepatocyte differentiation]] affects the reaction [Carbon Tetrachloride affects L-aspartate:2-oxoglutarate aminotransferase activity] 1: Mus musculus Embryonic Stem Cells   1
48. Oncostatin M hepatocyte differentiation alkaline phosphatase activity | Arsanilic Acid | Ascorbic Acid | Butyric Acid | Dexamethasone | Dimethyl Sulfoxide | EGF | HGF | Niacinamide [[EGF protein co-treated with Oncostatin M co-treated with Dexamethasone co-treated with Niacinamide co-treated with Ascorbic Acid] affects the reaction [[HGF protein co-treated with Dimethyl Sulfoxide co-treated with Butyric Acid] results in increased hepatocyte differentiation]] affects the reaction [Arsanilic Acid affects alkaline phosphatase activity] 1: Mus musculus Embryonic Stem Cells   1
49. Oncostatin M hepatocyte differentiation Ascorbic Acid | Butyric Acid | Dexamethasone | Dimethyl Sulfoxide | EGF | Fluorouracil | HGF | KRT18 | Niacinamide Fluorouracil inhibits the reaction [[[EGF protein co-treated with Oncostatin M co-treated with Dexamethasone co-treated with Niacinamide co-treated with Ascorbic Acid] affects the reaction [[HGF protein co-treated with Dimethyl Sulfoxide co-treated with Butyric Acid] results in increased hepatocyte differentiation]] which results in increased expression of KRT18 protein] 1: Mus musculus Embryonic Stem Cells   1
50. Oncostatin M lactate dehydrogenase activity Ascorbic Acid | Butyric Acid | Carbon Tetrachloride | Dexamethasone | Dimethyl Sulfoxide | EGF | hepatocyte differentiation | HGF | Niacinamide [[EGF protein co-treated with Oncostatin M co-treated with Dexamethasone co-treated with Niacinamide co-treated with Ascorbic Acid] affects the reaction [[HGF protein co-treated with Dimethyl Sulfoxide co-treated with Butyric Acid] results in increased hepatocyte differentiation]] affects the reaction [Carbon Tetrachloride affects lactate dehydrogenase activity] 1: Mus musculus Embryonic Stem Cells   1
1–50 of 60 results.